BR9306911A - Esteres 5-imidazol carboxílicos composições farmacêuticas método de tratamento de hipertensão em um animal de sangue quente e método de tratamento de colapso congestivo do coração em um animal de sangue quente e método de tratamento de colapso congestivo do coração em um animal de sangue quente - Google Patents
Esteres 5-imidazol carboxílicos composições farmacêuticas método de tratamento de hipertensão em um animal de sangue quente e método de tratamento de colapso congestivo do coração em um animal de sangue quente e método de tratamento de colapso congestivo do coração em um animal de sangue quenteInfo
- Publication number
- BR9306911A BR9306911A BR9306911A BR9306911A BR9306911A BR 9306911 A BR9306911 A BR 9306911A BR 9306911 A BR9306911 A BR 9306911A BR 9306911 A BR9306911 A BR 9306911A BR 9306911 A BR9306911 A BR 9306911A
- Authority
- BR
- Brazil
- Prior art keywords
- warm
- blooded animal
- congestive heart
- treating
- collapse
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US07/926,795 US5310929A (en) | 1992-08-06 | 1992-08-06 | Prodrugs of imidazole carboxylic acids as angiotensin II receptor antagonists |
| PCT/US1993/007103 WO1994003435A1 (en) | 1992-08-06 | 1993-08-02 | Prodrugs of imidazole carboxylic acids as angiotensin ii receptor antagonists |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR9306911A true BR9306911A (pt) | 1998-12-08 |
Family
ID=25453732
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR9306911A BR9306911A (pt) | 1992-08-06 | 1993-08-02 | Esteres 5-imidazol carboxílicos composições farmacêuticas método de tratamento de hipertensão em um animal de sangue quente e método de tratamento de colapso congestivo do coração em um animal de sangue quente e método de tratamento de colapso congestivo do coração em um animal de sangue quente |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US5310929A (pt) |
| EP (1) | EP0654027A1 (pt) |
| JP (1) | JP2892838B2 (pt) |
| CN (1) | CN1090275A (pt) |
| AU (1) | AU688735B2 (pt) |
| BR (1) | BR9306911A (pt) |
| CA (1) | CA2141692C (pt) |
| FI (1) | FI950485A0 (pt) |
| HU (1) | HU9500349D0 (pt) |
| IL (1) | IL106553A0 (pt) |
| MX (1) | MX9304787A (pt) |
| NO (1) | NO950404D0 (pt) |
| PL (1) | PL307309A1 (pt) |
| SG (1) | SG47108A1 (pt) |
| SK (1) | SK13195A3 (pt) |
| TW (1) | TW239131B (pt) |
| WO (1) | WO1994003435A1 (pt) |
| ZA (1) | ZA935693B (pt) |
Families Citing this family (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5616599A (en) * | 1991-02-21 | 1997-04-01 | Sankyo Company, Limited | Angiotensin II antagosist 1-biphenylmethylimidazole compounds and their therapeutic use |
| CZ283315B6 (cs) * | 1992-12-17 | 1998-02-18 | Sankyo Company Limited | Bifenylové deriváty, způsob výroby a farmaceutické prostředky k léčení hypertense a srdečních onemocnění, které tyto deriváty obsahují |
| KR100211446B1 (ko) * | 1994-03-16 | 1999-08-02 | 가와무라 요시부미 | 안압 저하제 |
| US6221335B1 (en) * | 1994-03-25 | 2001-04-24 | Isotechnika, Inc. | Method of using deuterated calcium channel blockers |
| US5510495A (en) * | 1994-09-19 | 1996-04-23 | The Du Pont Merck Pharmaceutical Company | Process for the isolation and purification of ester functionalized imidazole intermediates by selective hydrolysis |
| DE69507887T2 (de) * | 1994-09-20 | 1999-06-17 | Wakunaga Seiyaku K.K., Osaka | Verfahren zur herstellung von n-biphenylmethylthiadiazolin derivaten oder deren salzen sowie dafür benötigte zwischen verbindungen |
| IT1292437B1 (it) * | 1997-06-30 | 1999-02-08 | Zambon Spa | Processo di orto-metallazione utile per la sintesi di 1 - tetrazol- 5-il) benzeni 2-sostituiti |
| IT1295405B1 (it) * | 1997-09-30 | 1999-05-12 | Merck Sharp & Dohme Italia S P | Uso di un antagonista recettoriale di angiotensina ii per la preparazione di farmaci per aumentare il tasso di sopravvivenza di |
| DE19820064A1 (de) * | 1998-05-06 | 1999-11-11 | Hoechst Marion Roussel De Gmbh | Substituierte Sulfonylcyanamide, Verfahren zu ihrer Herstellung und ihre Verwendung als Medikament |
| DE19832429A1 (de) * | 1998-07-18 | 2000-01-20 | Hoechst Marion Roussel De Gmbh | Imidazolderivate mit Biphenylsulfonylsubstitution, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament |
| DE19832428A1 (de) * | 1998-07-18 | 2000-01-20 | Hoechst Marion Roussel De Gmbh | Imidazolderivate mit Biphenylsulfonylsubstitution, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament |
| ES2154191B1 (es) * | 1998-11-24 | 2001-10-16 | Ferrer Int | Nuevos acetales derivados de los 2-alquil-5-halo-3-(2'-(tetrazol-5-il)-bifenil-4-ilmetil)-3h-imidazol-4-carbaldehidos. |
| GR20000100281A (el) * | 2000-08-17 | 2002-05-24 | Ιωαννης Ματσουκας | Ανταγωνιστες του υποδοχεα της αγγεοτενσινης ιι και συνθετικες μεθοδοι για την θεραπεια της υπερτασης και καρδιοαγγειακων ασθενειων |
| AU2002257970B2 (en) | 2001-05-31 | 2007-08-02 | Vicore Pharma Ab | Tricyclic compounds useful as angiotensin II agonists |
| ES2281312T3 (es) * | 2003-01-16 | 2008-08-01 | Teva Pharmaceutical Industries Ltd. | Nueva sintesis de irbesartan. |
| ES2390967T3 (es) | 2004-01-20 | 2012-11-20 | Aichi Prefecture | Epítopo/péptido reconocido por LTC específico para Ep-CAM con restricción por ALH-A2402 y su utilización |
| US7157584B2 (en) * | 2004-02-25 | 2007-01-02 | Takeda Pharmaceutical Company Limited | Benzimidazole derivative and use thereof |
| KR100953878B1 (ko) * | 2004-09-02 | 2010-04-22 | 테바 파마슈티컬 인더스트리즈 리미티드 | 올메살탄 메독소밀의 정제 |
| US20070054948A1 (en) * | 2004-09-02 | 2007-03-08 | Lilach Hedvati | Purification of olmesartan medoxomil |
| WO2006115834A1 (en) * | 2005-04-20 | 2006-11-02 | Merck & Co., Inc. | Angiotensin ii receptor antagonists |
| JP2009515834A (ja) * | 2006-08-29 | 2009-04-16 | テバ ファーマシューティカル インダストリーズ リミティド | ５−フェニル−１−トリチル−１ｈ−テトラゾールの合成のための方法 |
| AU2007306171B2 (en) * | 2006-10-09 | 2013-02-21 | Cipla Limited | Process for preparing trityl olmesartan medoxomil and olmesartan medoxomil |
| WO2008067687A1 (fr) * | 2006-12-06 | 2008-06-12 | Shanghai Allist Pharmaceutical., Inc. | Sels de dérivés d'acide imidazol-5-carboxylique, procédés de préparation et utilisation |
| EP2521545B1 (en) * | 2010-01-07 | 2019-11-27 | Alkermes Pharma Ireland Limited | Prodrugs of heteroaromatic compounds |
| EP2455388A1 (en) | 2010-11-23 | 2012-05-23 | LanthioPep B.V. | Novel angiotensin type 2 (AT2) receptor agonists and uses thereof. |
| CN104610232B (zh) * | 2013-11-01 | 2019-09-20 | 深圳信立泰药业股份有限公司 | 阿利沙坦酯无定形及其制备方法及含所述无定形的药物组合物 |
| CN114514032A (zh) | 2019-08-02 | 2022-05-17 | 兰提欧派普有限公司 | 用于治疗癌症的血管紧张素2型(at2)受体激动剂 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5138069A (en) * | 1986-07-11 | 1992-08-11 | E. I. Du Pont De Nemours And Company | Angiotensin II receptor blocking imidazoles |
| CA1338238C (en) * | 1988-01-07 | 1996-04-09 | David John Carini | Angiotensin ii receptor blocking imidazoles and combinations thereof with diuretics and nsaids |
| EP0479892A1 (en) * | 1989-06-30 | 1992-04-15 | E.I. Du Pont De Nemours And Company | Fused-ring aryl substituted imidazoles |
| EP0479903B1 (en) * | 1989-06-30 | 1996-02-21 | E.I. Du Pont De Nemours And Company | Substituted imidazoles useful as angiotensin ii blockers |
| GB8927277D0 (en) * | 1989-12-01 | 1990-01-31 | Glaxo Group Ltd | Chemical compounds |
| US5196444A (en) * | 1990-04-27 | 1993-03-23 | Takeda Chemical Industries, Ltd. | 1-(cyclohexyloxycarbonyloxy)ethyl 2-ethoxy-1-[[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]benzimidazole-7-carboxylate and compositions and methods of pharmaceutical use thereof |
| US5137902A (en) * | 1990-07-13 | 1992-08-11 | E. I. Du Pont De Nemours And Company | 4-alkylimidazole derivatives and anti-hypertensive use thereof |
| DE69329982T2 (de) * | 1992-06-02 | 2001-09-27 | Sankyo Co., Ltd. | 4-Carboxyimidazolderivate als Angiotensin-II-Antagonisten und ihre therapeutische Verwendung |
-
1992
- 1992-08-06 US US07/926,795 patent/US5310929A/en not_active Expired - Lifetime
-
1993
- 1993-08-02 JP JP6505415A patent/JP2892838B2/ja not_active Expired - Lifetime
- 1993-08-02 HU HU9500349A patent/HU9500349D0/hu unknown
- 1993-08-02 AU AU47903/93A patent/AU688735B2/en not_active Ceased
- 1993-08-02 SK SK131-95A patent/SK13195A3/sk unknown
- 1993-08-02 IL IL106553A patent/IL106553A0/xx unknown
- 1993-08-02 BR BR9306911A patent/BR9306911A/pt not_active Application Discontinuation
- 1993-08-02 EP EP93918463A patent/EP0654027A1/en not_active Withdrawn
- 1993-08-02 CA CA002141692A patent/CA2141692C/en not_active Expired - Lifetime
- 1993-08-02 PL PL93307309A patent/PL307309A1/xx unknown
- 1993-08-02 WO PCT/US1993/007103 patent/WO1994003435A1/en not_active Application Discontinuation
- 1993-08-02 SG SG1996008109A patent/SG47108A1/en unknown
- 1993-08-05 ZA ZA935693A patent/ZA935693B/xx unknown
- 1993-08-06 CN CN93117634A patent/CN1090275A/zh active Pending
- 1993-08-06 MX MX9304787A patent/MX9304787A/es unknown
- 1993-08-06 TW TW082106302A patent/TW239131B/zh active
-
1995
- 1995-02-03 NO NO950404A patent/NO950404D0/no unknown
- 1995-02-03 FI FI950485A patent/FI950485A0/fi not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| CN1090275A (zh) | 1994-08-03 |
| US5310929A (en) | 1994-05-10 |
| AU4790393A (en) | 1994-03-03 |
| ZA935693B (en) | 1995-02-06 |
| EP0654027A1 (en) | 1995-05-24 |
| SG47108A1 (en) | 1998-03-20 |
| WO1994003435A1 (en) | 1994-02-17 |
| FI950485A (fi) | 1995-02-03 |
| JP2892838B2 (ja) | 1999-05-17 |
| AU688735B2 (en) | 1998-03-19 |
| SK13195A3 (en) | 1995-07-11 |
| PL307309A1 (en) | 1995-05-15 |
| CA2141692A1 (en) | 1994-02-17 |
| MX9304787A (es) | 1995-01-31 |
| TW239131B (pt) | 1995-01-21 |
| FI950485A0 (fi) | 1995-02-03 |
| JPH08500103A (ja) | 1996-01-09 |
| CA2141692C (en) | 2006-05-30 |
| IL106553A0 (en) | 1993-12-08 |
| NO950404D0 (no) | 1995-02-03 |
| HU9500349D0 (en) | 1995-03-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR9306911A (pt) | Esteres 5-imidazol carboxílicos composições farmacêuticas método de tratamento de hipertensão em um animal de sangue quente e método de tratamento de colapso congestivo do coração em um animal de sangue quente e método de tratamento de colapso congestivo do coração em um animal de sangue quente | |
| NO924978L (no) | Chinolon- og naftyridon-karboksylsyrederivater | |
| FI944336A (fi) | Ihon pH-arvon mukainen jäähdytinpuhdistuspala ja menetelmä sen valmistamiseksi | |
| HU9201609D0 (en) | Method for producing 4-[2-(2-hydroxi-2-phenyl-ethyl-amino)-ethoxi]-phenyl-acetic acid and its derivatives | |
| DK42093D0 (da) | Administrationsmetode | |
| HU9201186D0 (en) | Optically active secondary amines and method for producing said compounds as well as for producing optically active carboxylic acids using said compounds | |
| UA39172C2 (uk) | Похідні 2-(2,6-дигалофеніламіно) фенілоцтової кислоти і спосіб їх одержання | |
| IL103817A0 (en) | Method and intermediates for the preparation of prolineboronic acid esters | |
| FI980630A0 (fi) | Menetelmä klavulaanihapon valmistamiseksi | |
| DE59809575D1 (de) | Komplexe des lhrh-antagonisten cetrorelix mit polyaminosäuren sowie verfahren zu deren herstellung | |
| ATE142205T1 (de) | Substituierte piperidimylmethyl-ester von 3- indolcarbonsäure | |
| DE69313501D1 (de) | Verfahren zum Herstellen von Carbonsäureestern | |
| FI944138A (fi) | Menetelmä syntetoida entsymaattisesti peptidialkyyliestereitä, näin saadut tuotteet sekä mainittujen tuotteiden käyttö | |
| DE59308469D1 (de) | Fluorierte Carbonsäureester von Phosphono- und Phosphinocarbonsäuren sowie deren Verwendung | |
| ATA36189A (de) | Dioxancarbonsäuren, formylderivate ihrer ester und verfahren zu deren herstellung | |
| DE69405502D1 (de) | Verfahren zur herstellung von 2-fluor isobuttersäure und deren ester | |
| FI956177A (fi) | N-substituoituja atsaheterosyklisiä karboksyylihappoja ja näiden estereitä | |
| DE59404990D1 (de) | Fettsäureester von Methylglucosid-Derivaten | |
| ITMI930337A1 (it) | Esteri di acidi carbossilici di idrossifenilalcanoli come agenti stabilizzanti | |
| DE69413544D1 (de) | Reduzierte absorption von fettsäuren | |
| DE69221107D1 (de) | Propargylester von konjugiertethylenischer Unsättigung-enthaltende Carbonsäure sowie davon abgeleitete Organosiliziumverbindungen | |
| DE59305271D1 (de) | Verfahren zum stabilisieren von vinylether/maleinsäureanhydrid copolymerisaten | |
| KR950700429A (ko) | 강력강 부품과 그 제조 방법(High-strength steel parts and method of making) | |
| HU9202596D0 (en) | Method for producing new heterocyclic carboxylic acid esters and pharmaceutical preparatives containing said esters | |
| PL299713A1 (en) | Special 1,4-dihydropyridine 3,5-dicarboxylic ester, method of obtaining same and its application for pharmaceutical purposes |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA7 | Application withdrawn (art. 18 par. 1 of law 5772/71) - being contrary to morals, good customs and public security, order and health | ||
| HP | Claimed priority lost |